Saturday 7 November 2026 Export GLUE’s income statement to Excel — free account

Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $123.7 million, up 63.5% from fiscal 2024.

Revenue: +325.8%
EPS: +109.1%
Free cash flow: −142.6%

Quarter to September 2026, against a year earlier

10.49 0.24 +2.34%

Follow GLUE

Alert me

Market cap: $874.5M
P/E: 0.0×
Fwd P/E: −7.6×
Dividend yield: —
F-score: n/a
Altman Z: 2.89
Beneish M: 34.93
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	(35.30%)	(42.66%)	(32.62%)	(16.94%)	+8 more TTM periods Free account
ROA Full definition →	(22.63%)	(30.67%)	(23.02%)	(8.71%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(21.59%)	(26.78%)	(20.48%)	(10.88%)
Average Days of Receivables Full definition →	0.00	62.51	39.17	34.24
Free Cash Flow per Share Full definition →	(1.71)	(0.32)	(0.20)	(0.33)
Free Cash Flow Full definition →	(174.39)	(32.08)	(19.66)	(27.50)
Capital Expenditures Full definition →	(8.92)	(8.01)	(4.98)	(4.70)
Other line items
Cash ROIC Full definition →	(16.24%)	(2.89%)	(1.65%)	(4.51%)
Accounts Receivable Turnover Full definition →	0.00	7.88	14.28	21.01
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.01	(0.02)	(0.01)	(0.03)
Research and Development Expense of Revenue Full definition →	255.07%	594.18%	357.09%	114.42%
Selling, General and Administrative Expense of Revenue Full definition →	59.39%	138.86%	88.12%	29.42%
Share Based Compensation of Revenue Full definition →	32.07%	71.68%	45.44%	15.25%
Operating CF/Net income Full definition →	1.26	0.15	0.11	0.59
Depreciation/Fixed assets Full definition →	0.29	0.27	0.29	0.32
Capex/Depreciation Full definition →	(1.09)	(0.99)	(0.60)	(0.56)
Revenue per Share Full definition →	0.69	0.28	0.43	1.49
Operating CF per Share Full definition →	(1.63)	(0.24)	(0.15)	(0.27)
Capex per Share Full definition →	(0.09)	(0.08)	(0.05)	(0.06)
Capex to Sales Full definition →	0.13	0.28	0.12	0.04

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly